OTC: ARSUF - Fagron NV

Rentabilität für sechs Monate: -3.93%
Dividendenrendite: 0.00%

Aktionsplan Fagron NV


Über das Unternehmen Fagron NV

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding.

weitere details
Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.55
Дивиденд ао 0.2471
Сайт https://www.fagron.com
Цена ао 20.03
Preisänderung pro Tag: 0% (20.03)
Preisänderung pro Woche: 0% (20.03)
Preisänderung pro Monat: 0% (20.03)
Preisänderung über 3 Monate: 0% (20.03)
Preisänderung über sechs Monate: -3.93% (20.85)
Preisänderung pro Jahr: +7.75% (18.589)
Preisänderung seit Jahresbeginn: 0% (20.03)

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0.7143 7.14
Gesamt: 3.94

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 56.52 7
Rentabilität Ebitda, % 0 0
Rentabilität EPS, % 22.08 4
Gesamt: 5.4

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Rafael Padilla CEO & Executive Director 1.2M 1978 (47 Jahre)
Ms. Karin de Jong CFO & Executive Director 710.81k 1979 (46 Jahre)
Ms. Vera Bakker Chief Operating Officer 8.03k 1972 (53 Jahr)
Karen Berg Global Investor Relations Manager N/A
Mr. Johan Verlinden Head of Legal, Mergers & Acquisitions N/A

Adresse: Belgium, Nazareth, Venecoweg 20A - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.fagron.com